CAS 162641-16-9 HQL 79 - Analytical Products / Alfa Chemistry

1

[Hematopoietic Prostaglandin D Synthase Inhibitors for the Treatment of Duchenne Muscular Dystrophy]

Shinya Kamauchi, Yoshihiro Urade

Brain Nerve. 2011 Nov;63(11):1261-9.

PMID: 22068479

1

Pharmacological Studies on the Novel Antiallergic Drug HQL-79: I. Antiallergic and Antiasthmatic Effects in Various Experimental Models

N Matsushita, M Hizue, K Aritake, K Hayashi, A Takada, K Mitsui, M Hayashi, I Hirotsu, Y Kimura, T Tani, H Nakajima

Jpn J Pharmacol. 1998 Sep;78(1):1-10.

PMID: 9804056

1

Pharmacological Studies on the Novel Antiallergic Drug HQL-79: II. Elucidation of Mechanisms for Antiallergic and Antiasthmatic Effects

N Matsushita, K Aritake, A Takada, M Hizue, K Hayashi, K Mitsui, M Hayashi, I Hirotsu, Y Kimura, T Tani, H Nakajima

Jpn J Pharmacol. 1998 Sep;78(1):11-22.

PMID: 9804057

1

Protective Role of Hematopoietic Prostaglandin D Synthase in Transient Focal Cerebral Ischemia in Mice

M Liu, N Eguchi, Y Yamasaki, Y Urade, N Hattori, T Urabe

Neuroscience. 2009 Sep 29;163(1):296-307.

PMID: 19531375

1

Structural and Functional Characterization of HQL-79, an Orally Selective Inhibitor of Human Hematopoietic Prostaglandin D Synthase

Kosuke Aritake, Yuji Kado, Tsuyoshi Inoue, Masashi Miyano, Yoshihiro Urade

J Biol Chem. 2006 Jun 2;281(22):15277-86.

PMID: 16547010